Skip to main content

Advertisement

Log in

Assessment of survival prediction after surgery in spinal metastases patients using the Global Spine Study Tumor Group (GSTSG) risk calculator; an external validation from a tertiary cancer hospital

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Purpose

We aim to validate the Global Spine Tumor Study Group (GSTSG) score compared to previous prognostic scoring systems in spinal metastasis.

Methods

We conducted a retrospective study from January 2013 to December 2022. The survival prediction was compared between the GSTSG, Tomita Score, Revised Tokuhashi Score, and Skeletal Oncology Research Group (SORG) Nomogram. Single-variable factors associated with survival rate were analyzed using univariate Cox regression and multivariable Cox proportional hazard model. Receiver operating characteristic was used for external validity analysis at 3, 6, 12, and 24 months. The overall survival rate was reported using the Kaplan–Meier survival curve.

Results

248 spinal metastasis patients were included. The mean age was 59.23 ± 12.55 years. The mean duration of follow-up time was 470.29 ± 441.98 days. The external validity of GSTSG was the highest at all follow-up times (sufficiently accurate AUC > 0.7), which was about the same as SORG at 3 months (both AUC of GSTSG and SORG = 0.76) and higher than modified Tokuhashi and Tomita score at 12 months (AUC of GSTSG = 0.78, SORG = 0.71, Tomita = 0.64, and modified Tokuhashi = 0.61, respectively).

Conclusion

From our study, the Multivariate Cox regression analysis indicates that the significant factors related to survival rate are regular analgesic use of weak opioids, lung metastasis, and previous chemotherapy. Compared to other traditional spinal metastases prognostic scoring systems, GSTSG shows the highest AUC for external validity in all follow-up times up to 24 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Patchell RA, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648. https://doi.org/10.1016/S0140-6736(05)66954-1

    Article  PubMed  Google Scholar 

  3. Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz LT (1999) Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine (Phila Pa 1976) 24(18):1943–1951. https://doi.org/10.1097/00007632-199909150-00014

    Article  CAS  PubMed  Google Scholar 

  4. Groenen KHJ, van der Linden YM, Brouwer T et al (2018) The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management. Cancer Treat Rev 69:29–38. https://doi.org/10.1016/j.ctrv.2018.05.013

    Article  PubMed  Google Scholar 

  5. Ahmed AK, Goodwin CR, Heravi A et al (2018) Predicting survival for metastatic spine disease: a comparison of nine scoring systems. Spine J 18(10):1804–1814. https://doi.org/10.1016/j.spinee.2018.03.011

    Article  PubMed  Google Scholar 

  6. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26(3):298–306. https://doi.org/10.1097/00007632-200102010-00016

    Article  CAS  PubMed  Google Scholar 

  7. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 30(19):2186–2191. https://doi.org/10.1097/01.brs.0000180401.06919.a5

    Article  PubMed  Google Scholar 

  8. Paulino Pereira NR, Janssen SJ, van Dijk E, Harris MB, Hornicek FJ, Ferrone ML et al (2016) Development of a prognostic survival algorithm for patients with metastatic spine disease. J Bone Jt Surg 98(21):1767–1776. https://doi.org/10.2106/JBJS.15.00975

    Article  Google Scholar 

  9. Paulino Pereira NR, Mclaughlin L, Janssen SJ et al (2017) The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: external validation. J Surg Oncol 115(8):1019–1027. https://doi.org/10.1002/jso.24620

    Article  PubMed  Google Scholar 

  10. Choi D, Pavlou M, Omar R et al (2019) A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases; use of a large prospective patient database to personalise surgical management. Eur J Cancer 107:28–36. https://doi.org/10.1016/j.ejca.2018.11.011

    Article  PubMed  Google Scholar 

  11. Doyle DJ, Hendrix JM, Garmon EH (2023) American society of anesthesiologists classification. StatPearls Publishing, Treasure Island (FL)

    Google Scholar 

  12. Frankel HL, Hancock DO, Hyslop G et al (1969) The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Spinal Cord 7(3):179–192. https://doi.org/10.1038/sc.1969.30

    Article  CAS  Google Scholar 

  13. Karnofsky DA, Burchenal JH (1949) The Clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, pp 191–205

    Google Scholar 

  14. Zubrod CG, Schneiderman M, Frei E et al (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11(1):7–33. https://doi.org/10.1016/0021-9681(60)90137-5

    Article  Google Scholar 

  15. Zheng J, Ding X, Wu J et al (2023) Prognostic factors and outcomes of surgical intervention for patients with spinal metastases secondary to lung cancer: an update systematic review and meta analysis. Eur Spine J 32:228–243. https://doi.org/10.1007/s00586-022-07444-z

    Article  PubMed  Google Scholar 

  16. Paulino Pereira NR, Ogink PT, Groot OQ, Ferrone ML, Hornicek FJ, van Dijk CN et al (2019) Complications and reoperations after surgery for 647 patients with spine metastatic disease. Spine J 19(1):144–156. https://doi.org/10.1016/j.spinee.2018.05.037

    Article  PubMed  Google Scholar 

  17. Jaipanya P, Chanplakorn P (2022) Spinal metastasis: narrative reviews of the current evidence and treatment modalities. J Int Med Res 50(4):3000605221091665. https://doi.org/10.1177/03000605221091665

    Article  PubMed  Google Scholar 

  18. Esperança-Martins M, Roque D, Barroso T et al (2023) Multidisciplinary approach to spinal metastases and metastatic spinal cord compression-a new integrative flowchart for patient management. Cancers 15(6):1796. https://doi.org/10.3390/cancers15061796

    Article  PubMed  PubMed Central  Google Scholar 

  19. Pérez-Herrero E, Fernández-Medarde A (2015) Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79. https://doi.org/10.1016/j.ejpb.2015.03.018

    Article  CAS  PubMed  Google Scholar 

  20. Goetz LH, Schork NJ (2018) Personalized medicine: motivation, challenges, and progress. Fertil Steril 109(6):952–963. https://doi.org/10.1016/j.fertnstert.2018.05.006

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nater A, Chuang J, Liu K et al (2020) A personalized medicine approach for the management of spinal metastases with cord compression: development of a novel clinical prediction model for postoperative survival and quality of life. World Neurosurg 140:654–663. https://doi.org/10.1016/j.wneu.2020.03.098

    Article  PubMed  Google Scholar 

  22. Lee CC, Tey J, Cheo T, Lee CH, Wong A, Kumar N et al (2023) Outcomes of patients with spinal metastases from prostate cancer treated with conventionally-fractionated external beam radiation therapy. Glob Spine J 13(2):284–294. https://doi.org/10.1177/2192568221994798

    Article  Google Scholar 

  23. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 15(11):1110–1113. https://doi.org/10.1097/00007632-199011010-00005

    Article  CAS  PubMed  Google Scholar 

  24. Yen HK, Chen CW, Lin WH, Wang ZY, Huang CC, Chen HY et al (2022) Optimization of Tokuhashi scoring system to improve survival prediction in patients with spinal metastases. J Clin Med 11(18):5391. https://doi.org/10.3390/jcm11185391

    Article  PubMed  PubMed Central  Google Scholar 

  25. van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group (2005) Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103(2):320–328. https://doi.org/10.1002/cncr.20756

    Article  PubMed  Google Scholar 

  26. Bauer HC, Wedin R (1995) Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 66(2):143–146. https://doi.org/10.3109/17453679508995508

    Article  CAS  PubMed  Google Scholar 

  27. Bauer H, Tomita K, Kawahara N, Abdel-Wanis ME, Murakami H (2002) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 27(10):1124–1126. https://doi.org/10.1097/00007632-200205150-00027

    Article  PubMed  Google Scholar 

  28. Leithner A, Radl R, Gruber G et al (2008) Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 17(11):1488–1495. https://doi.org/10.1007/s00586-008-0763-1

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wibmer C, Leithner A, Hofmann G et al (2011) Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine (Phila Pa 1976) 36(23):1977–1986. https://doi.org/10.1097/BRS.0b013e3182011f84

    Article  PubMed  Google Scholar 

  30. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K (2005) Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Jt Surg Br 87(5):698–703. https://doi.org/10.1302/0301-620X.87B5.15185

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Wishuda Udomwongsub for English language editing and Data Management Unit, Centre of Learning and Research in Celebration of HRH Princess Chulabhorn’s 60th Birthday Anniversary, Chulabhorn Royal Academy for Statistical Analysis.

Author information

Authors and Affiliations

Authors

Contributions

Data collection: TW, AP, PN, WS, PM, TN; Methodology: TW, KJ, SS; Writing—original draft: TW; Writing—review & editing: TW, KJ, SS.

Corresponding author

Correspondence to Warayos Trathitephun.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by THAILAND.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trathitephun, W., Arunwatthanangkul, P., Pakmanee, N. et al. Assessment of survival prediction after surgery in spinal metastases patients using the Global Spine Study Tumor Group (GSTSG) risk calculator; an external validation from a tertiary cancer hospital. Eur Spine J (2024). https://doi.org/10.1007/s00586-024-08439-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00586-024-08439-8

Keywords

Navigation